tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR

Pharming Group (PHAR) Similar Stocks

Compare
132 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Pharming Group
$10.84
$767.67M
26.84%
1 Buy
0 Hold
0 Sell
Moderate Buy
KalVista Pharmaceuticals
$12.31
$603.80M
8.27%
9 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$23.39
$702.19M
2.18%
10 Buy
1 Hold
0 Sell
Strong Buy
Dianthus Therapeutics
$17.44
$585.95M
-29.90%
5 Buy
0 Hold
0 Sell
Strong Buy
Trevi Therapeutics
$6.07
$754.78M
125.65%
8 Buy
0 Hold
0 Sell
Strong Buy
Immunome
$8.83
$778.76M
-33.51%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAR
Pharming Group
10.84
2.68
32.84%
KALV
KalVista Pharmaceuticals
12.31
1.10
9.81%
ANAB
AnaptysBio
23.39
0.50
2.18%
DNTH
Dianthus Therapeutics
17.44
-8.42
-32.56%
TRVI
Trevi Therapeutics
6.07
3.43
129.92%
IMNM
Immunome
8.83
-3.75
-29.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis